hydroquinone has been researched along with dinoprostone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gaido, KW; Wierda, D | 1 |
| Alanko, J; Riutta, A; Vapaatalo, H | 1 |
| Doi, K; Fujimoto, Y; Fujita, T; Nagamatsu, S; Nishida, H; Sakuma, S | 1 |
| Garruto, J; Gotz, V; Herndon, JH; Makino, ET; Mehta, RC; Sigler, ML | 2 |
| Chang, BE; Chang, MC; Jeng, JH; Lee, MS; Lian, YC; Lin, BR; Lin, LD; Pan, YH; Yeung, SY | 1 |
2 trial(s) available for hydroquinone and dinoprostone
| Article | Year |
|---|---|
Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Topics: Adult; Aged; Antioxidants; Chemistry, Pharmaceutical; Color; Dermatologic Agents; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydroquinones; Hyperpigmentation; Middle Aged; Prostaglandin Antagonists; Surveys and Questionnaires; Treatment Outcome; Tretinoin | 2012 |
Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Topics: Administration, Cutaneous; Adult; Aged; Dermatologic Agents; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Face; Female; Follow-Up Studies; Humans; Hydroquinones; Hyperpigmentation; Middle Aged; Prostaglandin Antagonists; Severity of Illness Index; Surveys and Questionnaires; Time Factors | 2013 |
6 other study(ies) available for hydroquinone and dinoprostone
| Article | Year |
|---|---|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin.
Topics: Animals; Benzene; Bone Marrow; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Hydroquinones; Indomethacin; Male; Mice; Mice, Inbred Strains; Prostaglandin-Endoperoxide Synthases; Prostaglandins E | 1987 |
Phenols inhibit prostaglandin E2 synthesis in A23187-stimulated human whole blood and modify the ratio of arachidonic acid metabolites.
Topics: Arachidonic Acid; Calcimycin; Catechols; Dinoprostone; Humans; Hydroquinones; Neutrophils; Phenol; Phenols; Prostaglandin-Endoperoxide Synthases; Resorcinols; Thromboxane B2 | 1995 |
Existence of an enzymatic pathway furnishing arachidonic acid for prostaglandin synthesis from arachidonoyl CoA in rabbit kidney medulla.
Topics: Acyl Coenzyme A; Animals; Arachidonic Acid; Chromatography, High Pressure Liquid; Cytosol; Dinoprost; Dinoprostone; Glutathione; Hydroquinones; Kidney Medulla; Male; Microsomes; Prostaglandin D2; Prostaglandins; Rabbits | 1994 |
Antiplatelet, antioxidative, and anti-inflammatory effects of hydroquinone.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Platelets; Cells, Cultured; Cyclooxygenase 2; Dental Pulp; Dinoprost; Dinoprostone; Humans; Hydroquinones; Inflammation Mediators; Interleukin-8; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Signal Transduction; Thromboxane A2 | 2019 |